Brigham and Women’s Hospital, Harvard Medical School
Disclosure(s): Actelion: Grant/Research Support; Alnylam: Grant/Research Support; Amgen: Grant/Research Support; AstraZeneca: Grant/Research Support; Bayer: Grant/Research Support; Bellerophon: Grant/Research Support; BMS: Grant/Research Support; Celladon: Grant/Research Support; Cytokintetics: Grant/Research Support; Eidos: Grant/Research Support; Gilead: Grant/Research Support; GSK: Grant/Research Support; Ionis: Grant/Research Support; Lilly: Grant/Research Support; Mesoblast: Grant/Research Support; Myokardia: Grant/Research Support; Neurotronik: Grant/Research Support; NIH/NHLBI: Grant/Research Support; Novartis: Grant/Research Support, Honoraria; Novo Nordisk: Grant/Research Support; Sanofi: Grant/Research Support; Theracos: Grant/Research Support; US2.AI: Grant/Research Support